Search Results - technology+classifications+%3e+research+tools+%3e+nucleic+acids

34 Results Sort By:
Targeted capture of custom nucleotide sequences for single-cell sequencing
Value Proposition·      Implementation only requires simple modification of current capture beads.·      Allows for targeting of custom sequences of interest that may be cell-type specific or expressed at low levels.·      Targets RNA molecules without polyA tails.·      Inexpensive modification to existing commercial methods. Technology DescriptionResearchers...
Published: 9/27/2024   |   Inventor(s): Jonathan Ling, Katherine Irwin, Irika Sinha, Philip Wong, Linda Orzolek, Tyler Creamer
Keywords(s):  
Category(s): Technology Classifications > Research Tools > Nucleic Acids, Technology Classifications > Research Tools > Vectors & Plasmids, Technology Classifications > Research Tools > Assays
CRISPR/Cas9 and Tumor-Specific Guide RNAs as a Specific and Selective Cancer Cell Killing Biologic Platform
Value Proposition:Specific targeting of mutations can treat any cancer with the specified mutations.Selective cell killing spares healthy tissue while eliminating cancer cells. Pan-cancer efficacy as guide RNAs are developed to target a wide breadth of cancer-specific mutations.Lack of protospacer adjacent motif (PAM) sites in healthy host cells prevents...
Published: 9/27/2024   |   Inventor(s): James Eshleman, Selina Shiqing Teh, Kirsten Bowland, Nicholas Roberts
Keywords(s):  
Category(s): Clinical and Disease Specializations > Oncology, Clinical and Disease Specializations > Oncology > Pancreatic Ductal Adenocarcinoma, Clinical and Disease Specializations > Oncology > Pancreatic Cancer, Technology Classifications > Therapeutic Modalities > Biologics, Technology Classifications > Research Tools > Nucleic Acids
Compositions of Kinetic Nanoparticles containing Nucleic Acids, Polycations, and Lipids with Defined Sizes, and Methods of Producing the Same
Value Proposition:·        Scalable, efficient, and tunable nanoparticle creation technique that can deliver a variety of payloads·        Polymer-lipid nanoparticles are biodegradable and are being tested for immunogenicity·        Can be used for in vivo gene therapy delivery as well as in vitro cell transfection and research applications Technology...
Published: 9/27/2024   |   Inventor(s): Hai-Quan Mao, Stephany Tzeng, Jordan Green, Yizong Hu, Sashank Reddy, Leonardo Cheng
Keywords(s):  
Category(s): Clinical and Disease Specializations > Immuno-Oncology, Clinical and Disease Specializations > Oncology, Technology Classifications > Engineering Tech > Materials, Technology Classifications > Research Tools > Nucleic Acids, Technology Classifications > Research Tools > Peptides, Technology Classifications > Research Tools > Vectors & Plasmids, Technology Classifications > Therapeutic Modalities > Gene Therapies, Technology Classifications > Therapeutic Modalities > Peptides, Technology Classifications > Therapeutic Modalities > Proteins, Technology Classifications > Therapeutic Modalities > Therapeutic Delivery Platforms
Identification of RNF43 Mutations in Pancreatic Cysts
Unmet Need·        One third of diagnoses for surgical resection of pancreatic cysts are incorrect, leading to unnecessary surgery, medical risk, and high costs (Hammel, 2002). The current standard of care for determining pancreatic cyst type is based solely on symptom progression and imaging criteria, and histopathological analysis is only available...
Published: 9/26/2024   |   Inventor(s): Bert Vogelstein, Kenneth Kinzler, Nickolas Papadopoulos, Jian Wu, Anirban Maitra, Ralph Hruban, Marco Dal Molin
Keywords(s): Cancers, Cloning Reagents, Discovery/Research Tools, Disease Indication, Nucleotide, Pancreatic Cancer, Research Reagent, Translational Research Biomarker
Category(s): Clinical and Disease Specializations, Clinical and Disease Specializations > Gastroenterology, Technology Classifications > Research Tools > Nucleic Acids, Clinical and Disease Specializations > Oncology, Technology Classifications > Research Tools, Clinical and Disease Specializations > Oncology > Pancreatic Cancer, Technology Classifications > Diagnostics > Biomarkers, Technology Classifications > Diagnostics > Diagnostic Biomarkers
Repetitive Element Aneuploidy Sequencing Systems (REAL-SeqS)
Unmet NeedAneuploidies are chromosomal alterations that are present in the majority of cancers and associated with numerous genetic disorders. Consequently, the detection of aneuploidy in clinical samples has important applications in prenatal testing and cancer diagnostics. The current, noninvasive methods for detecting aneuploidy in clinical samples...
Published: 9/27/2024   |   Inventor(s): Bert Vogelstein, Kenneth Kinzler, Christopher Douville, Nickolas Papadopoulos, Cristian Tomasetti
Keywords(s): Analytical Method, Discovery/Research Tools, In Vitro Research Tool
Category(s): Technology Classifications > Research Tools > Nucleic Acids
Methods for Payload and Size Characterization of Nucleic Acid Nanoparticles
Polymeric and lipid nanoparticles (NPs) are an effective and safe method for therapeutic delivery. At each of the various steps in nanoparticle development and manufacturing (i.e., research and design, quality assurance), assessing the features of these vehicles is essential. Some features (i.e., packaging characteristics, cargo location, structure...
Published: 9/27/2024   |   Inventor(s): Tza-Huei Wang, Hai-Quan Mao, Sixuan Li, Yizong Hu, Andrew Li
Keywords(s):  
Category(s): Technology Classifications > Therapeutic Modalities > Therapeutic Delivery Platforms, Technology Classifications > Research Tools > Imaging, Technology Classifications > Research Tools > Nucleic Acids
Solid-phase Synthesis of Oligonucleotides Containing N6-(2-Deoxy-alpha,beta-D-erythropentofuranosyl)-2,6-diamino-4-hydroxy-5-formamidopyrimidine (Fapy•dG)
Unmet Need: Study of the common DNA damage oxidative lesion Fapy∙dG has been extremely limited due to the lack of tools available to synthesize oligonucleotides containing this lesion.   Technical Details: Johns Hopkins researchers have developed a solid-phase synthetic method to prepare oligonucleotides containing N6-(2-Deoxy-α,β-D-erythropentofuranosyl)-2,6-diamino-4-hydroxy-5-formamidopyrimidine...
Published: 9/27/2024   |   Inventor(s): Marc Greenberg, Haozhe Yang
Keywords(s):  
Category(s): Technology Classifications > Research Tools > Nucleic Acids
Very Fast and Efficient Light-inducible CRISPR/Cas9 System for Genome Editing
Unmet NeedSince CRISPR has been proposed as a genome editing tool in 2012, it has revolutionized the field and created excitement extending beyond the genome editing scientific community. Due to its simplicity and efficiency, CRISPR-Cas9 systems have already shown promise in multiple fields, e.g., medicine, agriculture and even biofuels (through CRISPR-edited...
Published: 9/27/2024   |   Inventor(s): Taekjip Ha, Yang Liu, Roger Zou, Bin Wu
Keywords(s): Discovery/Research Tools, Enzymes, Recombinant Proteins, Research Reagent
Category(s): Technology Classifications > Research Tools > Nucleic Acids
A CRISPR-Cas9 Platform with an Intrinsic Off-switch and Enhanced Specificity
Unmet NeedThe CRISPR/Cas9 system is a revolutionary genome editing tool that has opened up new opportunities in biological research and disease treatments. However, prolonged activity of Cas9 endonuclease inside the cell could undermine the efficacy of this system as it increases the risk of deleterious side-effects, such as off-target editing, genotoxicity,...
Published: 9/27/2024   |   Inventor(s): Taekjip Ha, Roger Zou, Yang Liu
Keywords(s): Discovery/Research Tools, Enzymes, Recombinant Proteins, Research Reagent
Category(s): Technology Classifications > Research Tools > Nucleic Acids
HIF-1(alpha)CA5: A Stable and Constitutively-Active Form of HIF-1(alpha)
Technical Overview: Animals and people are dependent on a continuous supply of O(2) for survival. Hypoxia-inducible factor 1 (HIF-1) is a transcription factor that regulates oxygen homeostasis and plays key roles in development, physiology, and disease.  Vascularization and vascular remodeling represent critical adaptive responses to tissue hypoxia...
Published: 9/26/2024   |   Inventor(s): Gregg Semenza
Keywords(s): Basic Research Biomarker, Cloning Reagents, Discovery/Research Tools, Nucleotide, Research Reagent
Category(s): Technology Classifications > Research Tools, Technology Classifications > Research Tools > Nucleic Acids
1 2 3 4 
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by Inteum